chitosan has been researched along with Sepsis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Báfica, A; de Matos Morawski, F; Dias, GBM; Formiga, R; Jost, CL; Parize, AL; Sousa, KAP; Spiller, F | 1 |
| Chen, F; Hai, W; Liu, J; Liu, Y; Wang, M; Zhang, Y | 1 |
| Abdelkader, A; Abdelkader, O; El-Gazayerly, ON; El-Mokhtar, MA; Elsabahy, M; Hamad, MA | 1 |
| Hiorth, M; Lagos, L; Ropstad, E; Smistad, G; Tandberg, J; Winther-Larsen, HC | 1 |
| Davydova, V; Krasikova, I; Solov'eva, T; Yermak, I | 1 |
| Jain, V; Mishra, PR; Pal, R; Shukla, P | 1 |
| Cho, EJ; Doh, KO; Hyun, H; Park, J; Snyder, PW; Tsifansky, MD; Wilson, EM; Yeo, Y | 1 |
| Bai, XF; Du, YG; Qiao, Y | 1 |
| Mishra, PR | 1 |
1 review(s) available for chitosan and Sepsis
| Article | Year |
|---|---|
Marine compounds with therapeutic potential in gram-negative sepsis.
Topics: Animals; Anti-Bacterial Agents; Aquatic Organisms; Carrageenan; Chitosan; Endotoxemia; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Lipid A; Sepsis | 2013 |
8 other study(ies) available for chitosan and Sepsis
| Article | Year |
|---|---|
Chitosan/genipin modified electrode for voltammetric determination of interleukin-6 as a biomarker of sepsis.
Topics: Animals; Biomarkers; Biosensing Techniques; Chitosan; Electrochemical Techniques; Electrodes; Immunoassay; Interleukin-6; Limit of Detection; Mice; Sepsis | 2023 |
Chitosan modified graphene field-effect transistor biosensor for ultrasensitive procalcitonin detection.
Topics: Biosensing Techniques; Chitosan; Graphite; Humans; Procalcitonin; Sepsis | 2024 |
Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Escherichia coli; Klebsiella pneumoniae; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Animal; Nanoparticles; Rats; Sepsis; Thienamycins | 2017 |
The Use of Chitosan-Coated Membrane Vesicles for Immunization Against Salmonid Rickettsial Septicemia in an Adult Zebrafish Model.
Topics: Adjuvants, Immunologic; Animals; Bacterial Vaccines; Chitosan; Cytoplasmic Vesicles; Disease Models, Animal; Fish Diseases; Fish Proteins; Gene Expression Regulation; Immunity, Innate; Immunization; Piscirickettsia; Piscirickettsiaceae Infections; Sepsis; Zebrafish | 2018 |
Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis.
Topics: Animals; Anti-Bacterial Agents; Cations; Chitosan; Ciprofloxacin; Deoxycholic Acid; Drug Carriers; Emulsions; Escherichia coli; Escherichia coli Infections; Lipopolysaccharides; Microbial Sensitivity Tests; Nanostructures; Particle Size; Peritonitis; Rats, Wistar; Sepsis; Technology, Pharmaceutical | 2014 |
Zwitterionic chitosan for the systemic treatment of sepsis.
Topics: Animals; Cell Line; Chemokine CXCL2; Chitosan; Disease Models, Animal; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Sepsis | 2016 |
Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress.
Topics: Animals; Catalase; Chitosan; Cytokines; Disease Models, Animal; Female; Glutathione; Kidney; Lipid Peroxidation; Lipopolysaccharides; Liver; Lung; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Oligosaccharides; Oxidative Stress; Sepsis; Survival Analysis | 2011 |
An investigation on the approach to target lipopolysaccharide through polymeric capped nano-structured formulation for the management of sepsis.
Topics: Animals; Anti-Infective Agents; Chitosan; Ciprofloxacin; Deoxycholic Acid; Drug Compounding; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Nanocapsules; Sepsis; Treatment Outcome | 2011 |